You are here

Roche

From no drugs to 3: Patients with spinal muscular atrophy now face hard choices

BioPharma Dive

Mon, 10/5/20 - 11:39 pm

spinal muscular atrophy

Genentech pays $200M for Vaccibody's phase 1 cancer vaccine

Fierce Biotech

Thu, 10/1/20 - 10:05 am

cancer vaccines

Fourth-quarter events to watch for big pharma

EP Vantage

Mon, 09/28/20 - 10:34 pm

clinical trials

Gilead Sciences

Alzheimer's disease

Bristol-Myers Squibb

'Rigged' healthcare? Genentech survey reveals unfair treatment among marginalized groups

Motley Fool

Sun, 09/27/20 - 11:05 pm

racial diversity

racial discrimination

Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved

Fierce Biotech

Wed, 09/23/20 - 10:46 am

Alzheimer's disease

Blueprint plots return to FDA with new Ayvakit data in rare condition — and the analysts cheer

Endpoints

Tue, 09/22/20 - 10:17 pm

Blueprint Medicines

Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field

Fierce Biotech

Mon, 09/21/20 - 10:28 am

inflammatory disease

ESMO: Roche’s Akt inhibitor scores slight win over J&J’s Zytiga

Fierce Biotech

Sun, 09/20/20 - 08:02 pm

prostate cancer

ESMO: Roche's mixed results put Tecentriq's triple-negative breast cancer use into question

Fierce Pharma

Sun, 09/20/20 - 07:57 pm

triple negative breast cancer

Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study

MedCity News

Sun, 09/20/20 - 07:32 pm

COVID-19 pneumonia

clinical trials

Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial

Pharmaforum

Fri, 09/18/20 - 10:42 am

clinical trials

Roche, already prepping 2021 launch, charts big expansion plans for Lucentis eye implant

Fierce Pharma

Thu, 09/17/20 - 11:04 pm

macular degeneration

wet age-related macular degeneration

Esmo 2020 preview – late-breaking immunotherapy

EP Vantage

Mon, 09/14/20 - 10:53 am

Bristol-Meyers Squibb

Sharp knives and hemophilia? No problem in Roche's new work-life miniseries

Fierce Pharma

Fri, 09/11/20 - 10:51 am

pharma marketing

FDA puts Roche's Tecentriq under the lens in breast cancer after recent trial flop

Fierce Pharma

Wed, 09/9/20 - 08:05 pm

triple negative breast cancer

clinical trials

Novartis, Roche fined $526M in France for alleged Lucentis marketing missteps

Fierce Pharma

Wed, 09/9/20 - 10:59 am

anti-competitive scheme

Big pharma spinouts grow up

EP Vantage

Tue, 09/8/20 - 10:53 am

Roche to launch 40M rapid coronavirus antigen tests per month, starting in Europe

Fierce Biotech

Thu, 09/3/20 - 10:18 am

Emergency Use Authorization

AbbVie keeps TV ad lead in July, Roche and Pfizer follow in mildly curbed pharma TV market

Fierce Pharma

Mon, 08/24/20 - 10:18 am

Is valrox dead?

EP Vantage

Thu, 08/20/20 - 11:09 am

Pages